Literature DB >> 26032012

C1q, antibodies and anti-C1q autoantibodies.

Frank J Beurskens1, Rosanne A van Schaarenburg2, Leendert A Trouw3.   

Abstract

The complement system has long been known for its role in combating infections. More recently the complement system is becoming increasingly appreciated for its role in processes that range from waste transport, immune tolerance and shaping of the adaptive immune response. Antibodies represent the humoral part of the adaptive immune response and the complement system interacts with antibodies in several ways. Activated complement fragments impact on the production of antibodies, the complement system gets activated by antibodies and complement proteins can be the target of (auto)antibodies. In this review, written to celebrate the contributions of Prof. Dr. M.R. Daha to the field of immunology and especially complement, we will focus on C1q and its various interactions with antibodies. We will specifically focus on the mechanisms by which C1q will interact with monomeric IgG versus polymerized IgG and fluid-phase IgM versus solid-phase IgM. In addition in this review we will discuss in detail how C1q itself is targeted by autoantibodies and how these autoantibodies are currently considered to play a role in human disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibodies; C1q; Complement

Mesh:

Substances:

Year:  2015        PMID: 26032012     DOI: 10.1016/j.molimm.2015.05.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

Review 1.  Production of complement components by cells of the immune system.

Authors:  R Lubbers; M F van Essen; C van Kooten; L A Trouw
Journal:  Clin Exp Immunol       Date:  2017-03-24       Impact factor: 4.330

2.  Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.

Authors:  Cécile Picard; Jean-Christophe Lega; Bruno Ranchin; Pierre Cochat; Natalia Cabrera; Nicole Fabien; Alexandre Belot
Journal:  Pediatr Nephrol       Date:  2017-03-25       Impact factor: 3.714

Review 3.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

Review 4.  The complement system as a potential therapeutic target in rheumatic disease.

Authors:  Leendert A Trouw; Matthew C Pickering; Anna M Blom
Journal:  Nat Rev Rheumatol       Date:  2017-08-10       Impact factor: 20.543

5.  Diffusion of Soluble Aggregates of THIOMABs and Bispecific Antibodies in Serum.

Authors:  Dennis R Goulet; Adam Zwolak; Mark L Chiu; Abhinav Nath; William M Atkins
Journal:  Biochemistry       Date:  2017-04-14       Impact factor: 3.162

6.  Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women.

Authors:  H Vitkova; J Jiskra; D Springer; Z Limanova; Z Telicka; J Bartakova; M Trendelenburg; E Potlukova
Journal:  Clin Exp Immunol       Date:  2016-08-12       Impact factor: 4.330

7.  Anti-C1q in systemic lupus erythematosus.

Authors:  G Stojan; M Petri
Journal:  Lupus       Date:  2016-07       Impact factor: 2.911

Review 8.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

9.  Can Cell Bound Complement Activation Products Predict Inherited Complement Deficiency in Systemic Lupus Erythematosus?

Authors:  Naveen Raj; Barry Waters
Journal:  Case Rep Rheumatol       Date:  2016-12-15

Review 10.  Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway.

Authors:  Ana Catarina Lunz Macedo; Lourdes Isaac
Journal:  Front Immunol       Date:  2016-02-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.